Hybrid transforming growth factors
CA 2082450 A1 · Owner: Ciba-Geigy Ag · Inventors: Kuhla, Jochen; Mcmaster, Gary Kent; Cox, David
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel hybrid Transforming Growth Factors The invention relates to novel hybrid TGF-Bs a process for the production of biologically active, dimeric hybrid proteins and pharmaceutical compositions comprising them. Hybrid TGF-Bs produced by this process can be used in various therapeutic modalities such as for the promotion and acceleration of wound healing and bone and tissue repair the treatment, of cancer, as a bone marrow protective agent mediator of cardioprotection, antiinflammatory or immunosuppressive agent or as a growth regulator in mammalian cell cultures.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 9, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 9, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 9, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.